Page last updated: 2024-08-24

fluorodopa f 18 and Aura

fluorodopa f 18 has been researched along with Aura in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biraben, A; Depaulis, A; Douaud, G; Remy, P; Ribeiro, MJ; Semah, F1
Biraben, A; Bouilleret, V; Chassoux, F; Ribeiro, MJ; Semah, F; Syrota, A; Taussig, D1

Trials

1 trial(s) available for fluorodopa f 18 and Aura

ArticleYear
Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:3

    Topics: Adult; Algorithms; Anticonvulsants; Basal Ganglia; Brain Mapping; Dihydroxyphenylalanine; Drug Resistance; Epilepsy; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2005

Other Studies

1 other study(ies) available for fluorodopa f 18 and Aura

ArticleYear
PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy.
    Neurology, 2004, Jul-13, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Anticonvulsants; Caudate Nucleus; Chromosome Disorders; Chromosomes, Human, Pair 20; Dihydroxyphenylalanine; Dopamine; Drug Resistance; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Fear; Female; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Ring Chromosomes; Status Epilepticus; Synaptic Transmission

2004